（1）干细胞及其外泌体在耳聋治疗和人工听觉植入物中的应用。

The application of stem cells and their exosomes in deafness treatment and auditory implants.

（2）气道变应性炎症的机制与新兴治疗。

The mechanism of upper airway allergic inflammation and novel therapy.

（3）低温等离子医学在头颈部鳞癌治疗中的应用。

Cold atmospheric plasma and its potential in the treatment of head and neck squamous cell carcinoma.

（1）太阳集团电子游戏研究员、博士生导师，附属第四人民医院耳鼻喉头颈外科执行主任、主任医师。

Consultant, Professor, PhD/MD supervisor, Dept. of Otorhinolaryngology and Head & Neck Surgery (ORL-HNS), School of Medicine, Tongji University.

（2）太阳集团电子游戏等离子医学及外科植入物中心主任。

Director, Plasma Medicine and Surgical Implants Centre (PMSIC), School of Medicine, Tongji University.

（3）英国皇家外科学院终身Fellow，爱尔兰皇家外科学院终身Fellow。

Fellow of Royal College of Surgeons of England (FRCS Eng), Fellow of Royal College of Surgeons in Ireland (FRCS Irl).

（4）英国医疗总会注册耳鼻喉头颈外科主任医师。

Registered consultant specialist of the General Medical Council (GMC) of UK.

临床上，持英国行医执照，完成了皇家外科学院全长10年的系统外科培训，获得了英联邦的最高外科认证，现任英国皇家外科学院主任医师。

Clinically, as a fully registered clinician in the UK, Dr Tan completed his comprehensive 10-year surgical training entirely in the United Kingdom and Ireland. He is currently a consultant ENT surgeon, and a Fellow of the Royal College of Surgeons, which is the top surgical qualification in the commonwealth countries.

主持的科研项目：

（1）“上海市海外高层次人才引进计划”长期项目。

‘Shanghai Qianren Program’, long-term project.

（2）“浦江人才计划”专项资金。

‘Pujiang Talent Program’, special funding.

（3）“国家自然科学基金”面上项目。

National Natural Science Foundation of China, general program

代表性文章：

1. Li, X. et al. (2023). Int J Mol Sci. (IF = 5.6)

2. Wang Y. et al. (2022). Front Cell Dev Biol. (IF = 5.5)

3. Li, D. et al. (2022). J Transl Med. (IF = 7.4)

4. Tan, F. et al. (2021). FASEB J. (IF = 4.8)

5. Tan, F. et al. (2020). Crit Rev Biotechnol. (IF=9.08)

6. Tan, F. et al. (2020). Stem Cell Research & Therapy. (IF=8.079)

7. Wang, Z. and Tan, F. (2020). Scand J Immunol. (IF=3.889)

8. Tan, F. et al. (2020). Acta Biomater. (IF=10.633)

9. Tan, F. and Al-Rubeai, M. (2020). Drug Deliv Transl Res. (IF=5.88)

10. Tan, F. and Al-Rubeai, M. (2019). Front Bioeng Biotechnol. (IF=5.7)

11. Tan, F. et al. (2018). Auris Nasus Larynx. (IF=2.119)

12. Tan, F. et al. (2013). Cell Trends Biotechnol. (IF=17.3)

13. Tan, F. et al. (2024). Signal Transduction and Targeted Therapy. (IF=40)

14. Wang, Y. et al. (2024). Redox Biology. (IF=11.3)

学术上，长期从事耳鼻喉头颈外科的临床和基础研究，以及例如人工耳蜗等生物材料、生物技术、生物医学工程等交叉学科的研究，并主持了欧盟的国家级课题。归国后，主持了多个省部级课题和一项国自然面上项目，获得了2个科研人才计划，并于国际著名期刊发表了30余篇含影响因子40分以上的SCI文章。申请国家专利1项。荣获太阳集团电子游戏全英文讲课比赛特等奖。

Academically, Professor Tan has been heavily involved in the clinical and basic science research in otorhinolaryngology and head & neck surgery. He also devoted himself to conducting interdisciplinary research, such as biomaterial, biotechnology, and biomedical engineering, with copious translational success.

Upon return to Shanghai, Dr Tan is employed as a registered foreign expert. Research-wise, Professor Tan is hosting several research projects, and has published a dozen of papers with high impact factors in prestigious journals. Teaching-wise, Professor Tan is mentoring undergraduates, postgraduates, and qualified doctors of Tongji University. As a result of extraordinary performance, he recently received few talent awards.